4′‐ <i>C</i> ‐Aminoethoxy‐Modified DNAs Exhibit Increased Nuclease Resistance, Sustained RNase H Activity, and Inhibition of <i>KRAS</i> Gene Expression
4′‐ <i>C</i> ‐Aminoethoxy‐Modified DNAs Exhibit Increased Nuclease Resistance, Sustained RNase H Activity, and Inhibition of <i>KRAS</i> Gene Expression
复制标题
4′-<i>C</i>-氨基乙氧基修饰的 DNA 表现出增强的核酸酶抗性、持续的 RNase H 活性以及对 <i>KRAS</i> 基因表达的抑制
DOI:
10.1002/cbdv.202200125
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Ueno Yoshihito
中科院分区:
文献类型:
--
作者:
Katsuzaki Yuki;Tsukimura Ryo;Chandela Akash;Chano Tokuhiro;Ueno Yoshihito
The linear synthesis of 4′‐C‐aminoethoxy thymidine (AEoT) nucleoside phosphoramidite was accomplished using deoxythymidine as the starting material. This analog was incorporated into several oligonucleotides, the applicability of which as antisense oligonucleotides (ASOs) was then evaluated. The AEoT‐modified DNA/RNA duplex exhibited improved thermal stability compared to unmodified and 4′‐C‐aminoethyl thymidine (4′‐AET) modified heteroduplexes. The serum stability of AEoT‐modified DNA was notably increased by several‐folds compared to that of unmodified DNA. Furthermore, RNase H‐dependent cleavage of the modified‐DNA/RNA hybrids was found to be sustained. In addition, the modified antisense and unmodified oligonucleotides also displayed relatively comparable inhibition of theKRASgene in human lung cancer cells. This study strengthens our understanding of the potential application of 4′‐C‐aminoethoxy‐modified nucleotides as ASO therapeutics.